Vaspin Attenuates Atrial Abnormalities by Promoting ULK1/FUNDC1-Mediated Mitophagy
Table 1
Clinical characteristics of patients in the SR and AF group.
Variables
SR group ()
AF group ()
Age (y)
0.533
Gender (%male)
39 (53.4)
56 (62.2)
0.259
BMI (kg/m2)
0.078
Smoking (%)
12 (16.4)
13 (14.4)
0.726
Drinking (%)
6 (8.2)
14 (15.6)
0.157
Hypertension (%)
35 (47.9)
50 (55.5)
0.335
Type II diabetes (%)
8 (10.9)
15 (16.7)
0.299
Hypercholesterolemia (%)
5 (6.8)
4 (4.4)
0.505
Echocardiography
LVEF (%)
0.393
LAD (mm)
0.009
Laboratory
BNP (pg/mL)
<0.001
TG (mmol/L)
0.365
TC (mmol/L)
0.903
LDL-c (mmol/L)
0.535
HDL-c (mmol/L)
0.144
Vaspin concentration (ng/mL)
<0.001
MMP2 concentration (ng/mL)
0.025
TGF-β concentration (ng/mL)
<0.001
Data expressed as . BMI: body mass index; LVEF: left ventricular ejection fraction; LAD: left atrium dimension; BNP: B-type natriuretic peptide; HDL-c: high density lipoprotein-cholesterol; LDL-c: low density lipoprotein-cholesterol; TG: triacylglycerol; TC: total cholesterol.
